The possible role of human papillomavirus (HPV) in the aetiology of papillary tumor of the bladder has been evaluated and a review of the literature concerning this issue was made. A group of 17 patients affected by bladder papillary tumor was analysed. Surgical specimens were collected for virological and histological analysis. The DNA of the following viruses was searched by polymerase chain reaction (PCR): Adenovirus, Herpes simplex virus type 1(HSV ·1), Herpes simplex virus type 2 (HSV.2), Human Papillomaviruses (HPV), Polyomaviruses (BKV and JCV). The results showed that 15/17 (88 %) patients with papillary bladder tumor were found negative for each viral-searched DNA; only one sample was positive for HPV (6 % ) genotype 6, which is considered to convey a low risk for cancer development and only one was positive for BKV (6%). From the results obtained there seems to be no relationship between viral infection and the presence of bladder papillary tumor. Moreover, in the examined population the association bladder carcinoma-HPV, found by others, has not been confirmed. The homogeneity of the specimens studied was such that it would not be affected by the temporal factor, as were cases of more or less advanced cancers. Nonetheless specimens from patients with advanced cancers (G III) were negative to HPV infection. The data do not appear indicative for a correlation between viral DNA presence and histological parameters. Thus, in the light of the data emerging from this investigation, no causal relationship can be established between HPV infection and papillary bladder tumors.
Urothelial cell carcinoma of the urinary bladder is the most common form of bladder cancer. Approximately 80% of these bladder tumors are superficial papillary lesions, confined to the mucosa or invading the lamina propria. (1) . Most malignant bladder lesions are transitional cell carcinomas, whereas the remaining neoplasms are squamous cell carcinomas and adenocarcinomas. Approximately 30% of bladder carcinomas appear as multiple lesions at the time of initial diagnosis.
Tumors are graded according to the degree of cellular abnormality, with the most atypical cells designated as high-grade tumors, while staging is based on the depth of invasion into the bladder muscle and surround structures. The stage refers to how far a cancer has progressed anatomically, while the grade refers to cell appearance (differentiation) and DNA make up. The American Joint Committee on Cancer (AJCC) to define bladder cancer has designated staging by TNM classification. The stage is determined by the depth in which the tumor has penetrated the bladder wall (T), by the assessment of invasion of lymph nodes (N) and other surrounding organs and tissues The World Health Organization (WHO) classification recognizes three grades ofurothelial carcinoma. The grading, defined pathologically from the bladder biopsy, gives us an idea of how fast the cancer might be growing or how aggressive it might be. High-grade cancers grow faster and spread earlier than low-grade cancers. The current system of grading uses only three different grades: well differentiated, moderately differentiated and poorly differentiated (or Grade I, II or III).
This system appears to correlate significantly with the natural history of transitional cell carcinoma: the higher the grade of the diagnosis, the higher the incidence of death from the disease within two years. Overall, the 5-year survival rate is 76% for whites and 55% for blacks (2) . Invasive bladder tumors tend to spread rapidly to the regional lymph nodes and then into adjacent structures.
Previous studies have shown an association of HPV infections with bladder cancer (3). In fact, HPV has been implicated in the pathogenesis of several human cancer (4). Among these, genital cancers are the best studied and the role of HPV has been firmly established (5) . HPV can be subdivided into low-risk type, e.g. HPV 6 and 11, associated with benign lesions like condylomata, and high-risk types, with 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68 being associated with cancer, and the latter group now being considered as human carcinogens of Group I (6-7). Several studies have therefore addressed the possible role of high-risk HPV in human bladder cancer, with conflicting results (8) (9) (10) .
In human cancer a role has also been suggested for the two human polyomaviruses, lCV and BKV, primarily associated with progressive multifocal leucoencephalopathy (PML) and hemorrhagic cystitis (HC), respectively. After the initial infection, primarily unapparent and without clinical signs, the viruses disseminate and establish a persistent infection in the urinary tract, lymphocytes, and in case of lCV, in the brain (26) . In particular, little it is known about the molecular aspects of how BKV contributes to HC in the bladder, which can also be caused by adenovirus infection (12) . Whether there is a reservoir of BKV in the bladder that reactivates upon immunosuppression or whether it moves from kidney to bladder at that time is not clear, although there is some evidence of the presence of BKV in a normal bladder (29) . There is a long way to establish proof that human polyomaviruses either directly cause human cancer or act as a cofactor, although evidence implicating the two viruses in various types of human tumors has accumulated over the years (11).
Both human adenoviruses and herpes simplex viruses (HSV) type I and 2 are commonly recognized for their capability to cause chronic and latent infections within the urogenital tract (12) (13) . The detection of HSV in mixed infections is relevant since it has been suggested that this virus interacts with HPV leading to an increased incidence of cervical carcinoma (14) . In addition the oncogenic potential of the adenoviruses propels this group of agents into the forefront of molecular biological research. However, at this time the adenoviruses have not been associated convincingly with any human malignancies (15) (16) .
In the present investigation, an attempt has been made to establish whether HPV or other viral agents could playa role in the aetiology of primary papillary tumor of the bladder. Attention was focused on this possibility following the reports of Aynaud et al. (17) and Griffiths (18) . Indeed, in these studies, it was curious to find that the correlation between positivity to HPV and ranging from 0 to 80%. From a review of the literature, it is feasible to hypothesize a causal relationship between papillary bladder tumor and HPV infection. An attempt has been made to establish whether the experience of other researchers corresponds with this investigation.
MATERIALS AND METHODS

Patient population
A group of 17 patients (16 males and 1 female) affected by papillary bladder tumor was analysed. The average age of the patients was 65. They all underwent trans-urethral resection of the tumor (TURB). A control group of 17 subjects (12 males and 5 females) was analysed. In this case autoptic samples of healthy bladder were collected. The average age of the control subjects was 59. Surgical specimens were collected for histological and virological analysis. In the latter case the presence of DNA of the following viruses were searched by polymerase chain reaction (PCR): Adenovirus, HSV-1, HSV-2, HPV, BKV and lCV.
Processing of clinical specimens
Samples were incubated in lysis buffer (0.5 M TRIS, 0.02 M EDTA, 0.01 M NaCI, 1% SDS) with 200 mg/ml proteinase K at 55°C for 24 h. Digestion was followed by phenol-chloroform extraction and ethanol precipitation. One mg of total purified DNA was used for each PCR.
Condition for PCR
DNA suitability for analysis was checked by amplification ofthe b-globin gene sequence (19) . General precautions, conditions for PCR analysis and nested PCR procedures were as published (20) (21) : b-globinpositive samples were amplified in a GeneAmp PCR System 9600 (Perkin-Elmer Cetus, Emeryville, CA), and all assays included positive and negative controls (22) . The PCR products were detected by ethidium bromide staining after electrophoretic migration through 2% agarose gels.
PCR for Adenovirus detection
According to Allard et al. (23) the PCR method was used for diagnosing adenovirus infection. A specific target DNA sequence (308 bp) was amplified by PCR using the hexon region primers hexAA 1885 and hexAAl9l3.
PCR for HSV detection
Three oligonucleotide primers were utilized in the HSV type-specific PCR according to the nucleotide sequence of the HSV DNA polymerase gene. Primer I was HSV type I specific, primer 3 was HSV type 2 specific and primer 2 was selected from the regions where HSV type 1and 2 are identical. The combination of primers 1 and 2 and that of primers 2 and 3 were designed to amplify DNA specific to HSV-I (469 bp) and HSV-2 (391 bp) of the DNA polymerase gene, respectively. The PCR amplification was performed according to Kimura et al. (24) .
PCRfor HPV detection
The amplification of a 450 bp fragment from L1 region of HPV DNA using the primer pair MY09 and MYII was performed as previously described (25) . This pair of degenerated consensus primers allows the detection of almost all the known types of HPV and, if the degree of homology is high, also new types.
HPV genotyping
PCR products corresponding to a 450 bp fragment were purified and sequenced; briefly, amplified products were purified with QIAquick PCR purification kit, according to QIAGEN protocol. DNA sequencing was performed by automatic DNA sequencer (Applied Biosystem, mod. 370 A) according to Manufacturer's specifications (Amplicycle Kit, Applied Biosystem). Analyses of nucleotide sequence were performed using the GCG (Genetic Computer Group) package version 10 in order to compare the amplified DNA with all the known HPV and determine the specific genotype.
PCR for Polyomaviruses detection
Nested PCR employed two pairs of primers that anneal to the invariant regions flanking the non-coding control region (NCCR) of BKV and ICV (20) (21) . Primers BKTTl (+) and BKTT2 (-) generated a 748 bp DNA fragment for BKV and a 724 bp DNA fragment for ICV after 40 amplification cycles.
The second pairs, B K I (+) and BK2 (-) speci fie for BKV, andICI (-) and IC2 (+) specific for ICV, amplified a portion of the first round PCR product, generating a fragment of 354 bp and 308 bp respectively (27) .
RESULTS
Human papilloma viruses have been implicated in the pathogenesis of several human cancers (4) . Several studies have therefore addressed the possible role of high-risk HPV in human bladder cancer with discrepant results (8) (9) (10) .
In human cancer a role has also been suggested for the human polyoma viruses IC and BK, primarily associated with PML and HC, respectively. It is fair to state that there is no conclusive proof that either human polyomaviruses directly cause human cancers, or act as a cofactor, although evidence implicating the two viruses in various types of human tumors has accumulated over the years (1 I) . Both human adenoviruses and herpes simplex viruses (HSV) type I and 2 are commonly recognised for their capability to cause chronic and latent infections within the urogenital tract (12) (13) .
In this study the correlation between different viral infections (ICV, BKV, HPV, HSV-l, HSV-2 and Adenovirus) and bladder papillary tumor has been evaluated. Among the studied group, of 18 patients with papillary bladder tumor, 15/17 (88 %) patients were found to be negati ve for each viral DNA searched. Only one sample was positi- ve for HPV (6%) genotype 6 ( Fig. 1 b) , which is considered a low risk for cancer development, and only one was positive to BKV (6%) (Fig. 1a, Fig.   2 ).
The homogeneity of the specimens studied was such that it would not be affected by the temporal factor, as were cases of more or less advanced cancers. Nonetheless, even those specimens from patients with advanced cancers (G III), were negative to HPV infection. In fact, the patients that were positive for HPV and BKV infection were in Ta G 1-G2 and in T1 G2 state, respectively (Tab. I).
DISCUSSION
The correlation between different viral infections and bladder papillary tumor was evaluated in this study. In the light of the data emerging from this investigation no causal relationship exists between viral infection and papillary bladder cancer. Among all the patients, only one was HPV positive for genotype 6, which is considered to promote a low risk for the development of cancer and only one was found positive for BKV. The role ofBKV in human cancers is still uncertain because of its ubiquity in the human population and the presence ofBKV DNA sequences in normal human tissues during latency and in different tumors (28) . In particular the hypothesis for urinary tract tumors is controversial (29) (30) . Moreover, the data do not appear to indicate a correlation between the presence of viral DNA and histological parameters, since the samples collected from patients with advanced cancer were negative for HPV infection. In fact, the patient found positive for HPV was in Ta G 1-G2 stage and the BKV-positive patient was in TI G2 stage (Tab. I), therefore the data does not appear to be indicative for a correlation between viral DNA presence and histological parameters (29) . Nevertheless, because the numberofpatients is relatively low, we can't exclude a possible viral aetiology for papillary bladder cancer. Considering that Herpes virus, as well as human papilloma virus and polyoma virus, BK may be included in the often cited "hit and run" theory (29-31), therefore we can't exclude a possible viral involvement in the earliest cancer stages.
In our future studies, we plan to reverse the research procedure; patients with HPV will be evaluated for development of bladder cancer. This should offer useful information concerning the aetiology and pathology of this cancer.
